Status:

COMPLETED

Investigating the Impact of Mode of Administration on Item Response

Lead Sponsor:

Stony Brook University

Collaborating Sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

QualityMetrics

Conditions:

Chronic Obstructive Pulmonary Disease

Depression

Eligibility:

All Genders

18+ years

Brief Summary

The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH Roadmap initiative to develop a computerized system measuring patient-reported outcomes in respondents with a wide range...

Detailed Description

This study is designed to systematically test the impact of mode of administration on patient-reported outcomes measures included in the PROMIS item banks. It is designed as a randomized cross-over st...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis given by treating physician
  • Respondents required to take one or more of the following medications for their treatment:
  • COPD: Inhalative steroids (e.g., budesonide, beclometasone), oral medication with theophylline (dimethylxanthine), 2 mimetic (e.g., formoterol, salmeterol), leukotriene antagonists (e.g., montelukast), or oral corticosteroids (e.g., prednisolone)
  • DEP: Anti-depressive drugs (e.g., mirtazapine, escitalopram) and/or received a recognized psychotherapeutic treatment for depression within the last year
  • RA: Anti-inflammatory medications (e.g., Cox-2 inhibitors, acetylsalicylic acid of more than 500mg/d, diclofenac, ibuprofen), immunosuppressants (e.g., methotrexate, leflunomide), immune modulators (e.g., infliximab, etanercept), or steroids (e.g., prednisolone) for current treatment of RA
  • Fluent in English
  • Have Internet access and an e-mail address (for the IVR-PC, PP-PC and PC-PC arms)
  • Willing and able to give informed consent

Exclusion

    Key Trial Info

    Start Date :

    April 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2009

    Estimated Enrollment :

    800 Patients enrolled

    Trial Details

    Trial ID

    NCT00783991

    Start Date

    April 1 2009

    End Date

    December 1 2009

    Last Update

    June 6 2013

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Polimetrix

    Palo Alto, California, United States, 94301

    2

    Rheumatology Associates of Long Island

    Smithtown, New York, United States, 11787

    Investigating the Impact of Mode of Administration on Item Response | DecenTrialz